Randomized controlled trial for traditional Chinese medicine in the prevention of novel coronavirus pneumonia (COVID-19) in high risk population

Status

Active, not recruiting

Phases

Early Phase 1

Study type

Interventional

Source

ITMCTR

Registry ID

ITMCTR2000002951

Enrollment

Unknown

Registered

2020-02-01

Start date

2020-02-01

Completion date

Unknown

Last updated

2023-02-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

novel coronavirus pneumonia (COVID-19)

Interventions

Community exposure TCM intervention group:TCM intervention

Hospital exposure TCM intervention group:TCM intervention

Hospital suspected TCM intervention group:TCM intervention

Community suspected control group:Placebo

Community exposure control group:Placebo

Hospital exposure control group:Placebo

Community suspected TCM intervention group:TCM intervention

Hospital suspected control group:Placebo

Eligibility

Sex/Gender

All

Age

18 Years to 60 Years

Inclusion criteria

Inclusion criteria: 1. aged 18 to 60 years 2. to be confirmed with a exposure history of diagnosed population within last 14 days; 3. with fever, positive results of blood routine examination and positive findings in CT examination, any two in three items met.

Exclusion criteria

Exclusion criteria: 1. Pregnancy or lactation; 2. Previous serious chronic basic diseases; 3. Previous allergy to traditional Chinese medicine; 4. Newly diagnosed 2019-nCOV pneumonia.

Design outcomes

Primary

Measure	Time frame
Height;Blood routine examination;Weight;Viral nucleic acid detection;Temperature;CT Scan of the Lungs;	—

Secondary

Measure	Time frame
Blood pressure;Hepatorenal function;Heart rate;	—

Countries

China

Contacts

Public ContactWei Li

Wuhan 1st Hospital

whsdyyykjc@126.com+86 13163283819

Outcome results

None listed

Source: ITMCTR (via WHO ICTRP) · Data processed: Feb 4, 2026